Introduction

Managing cervical metastatic lymph nodes requires high precision. Consequently, clinicians often seek minimally invasive options for salvage therapy. One such approach is I-125 seed implantation, which provides localized radiation directly to the tumor. This technique utilizes ultrasound guidance to ensure the accurate placement of radioactive seeds. Furthermore, it spares surrounding healthy tissues from excessive radiation exposure. This study explores the efficacy and safety of this procedure for patients with challenging metastatic nodes.

Improving Outcomes with I-125 Seed Implantation

Researchers conducted a retrospective analysis of 29 patients involving 53 metastatic lymph nodes. Specifically, they performed the procedure between 2021 and 2023 under real-time ultrasound guidance. The technical success rate reached 100% for all participants. Moreover, the results showed impressive local tumor control rates. At the three-month mark, the control rate stood at 90.5%. Similarly, it remained high at 91.1% by six months. Although it decreased to 75.9% at one year, the overall local control remains significant for this patient population.

Safety and Complication Profile

Safety is a critical consideration for any radioactive intervention. Fortunately, the study reported a highly favorable safety profile for this treatment modality. Only one patient (3.4%) experienced a minor skin injury during the follow-up period. Additionally, other adverse events were categorized as minor and easily manageable. Survival data indicated 1-year and 2-year rates of 55.2% and 37.9%, respectively. However, these figures should be interpreted carefully due to the small sample size. Nevertheless, the low morbidity makes it an attractive salvage therapy option.

Clinical Feasibility and Conclusion

The findings confirm that ultrasound-guided procedures are both feasible and effective. Therefore, this treatment serves as a valuable alternative when surgery or conventional external beam radiation is not viable. Overall, the high rate of local control combined with minimal complications suggests a strong role for this therapy in oncology. Clinicians should consider these benefits when planning multi-modal management for head and neck cancers.

Frequently Asked Questions

What are the primary benefits of I-125 seed implantation?

This procedure offers high technical success and impressive local tumor control rates. It is minimally invasive and reduces the risk of injury to adjacent vital structures compared to traditional surgery.

Is ultrasound-guided implantation safe?

Yes, research shows a low complication rate, with only minor skin injuries reported in a small percentage of cases. Most adverse events are manageable and do not lead to long-term morbidity.

When is this treatment typically used?

It is often used as a salvage or alternative therapy for metastatic cervical lymph nodes, especially in cases where surgery or external radiation is clinically challenging or impossible.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not a substitute for professional clinical judgment or a formal consultation. Refer to the latest local and national guidelines for clinical practice.

References

1. Li H et al. Ultrasound-Guided Iodine-125 Seed Implantation for Cervical Metastatic Lymph Nodes: An Analysis of Efficacy and Safety. J Ultrasound Med. 2026 May 25. doi: 10.1002/jum.70303. PMID: 42184129.


2. Huang MW et al. Five-year outcome of ultrasound-guided interstitial permanent 125I seeds implantation for local head and neck recurrent tumors. J Contemp Brachytherapy. 2019;11(1):28-34.


3. Zhang L et al. Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma. BMC Cancer. 2021;21:832.